What can cause hyperprolactinemia, and can escitalopram (Lexapro) be used to treat the elevation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lexapro Does NOT Treat Elevated Prolactin—It Can Actually CAUSE It

No, Lexapro (escitalopram) cannot help with prolactin elevation and may actually be a cause of hyperprolactinemia itself. SSRIs like Lexapro are among the medications that can induce hyperprolactinemia, not treat it 1, 2.

What Causes Hyperprolactinemia

Hyperprolactinemia has multiple etiologies that must be systematically evaluated:

Medication-Induced Causes (Most Common Drug-Related)

  • Antipsychotics: Conventional antipsychotics and some atypicals (risperidone, paliperidone, amisulpride) are the most frequent culprits 3, 4
  • Antidepressants: SSRIs including escitalopram (Lexapro), citalopram, fluoxetine, sertraline, and paroxetine can all cause hyperprolactinemia 1, 2
  • Antihypertensives: Various blood pressure medications 4, 5
  • Prokinetic agents: Medications that increase bowel motility 3, 4

Pathologic Causes

  • Prolactinomas: Pituitary adenomas (microadenomas <10mm or macroadenomas ≥10mm) 6
  • Other pituitary/hypothalamic lesions: Must be excluded with MRI 7
  • Idiopathic hyperprolactinemia 6

Mechanism of SSRI-Induced Hyperprolactinemia

SSRIs elevate prolactin through serotonin stimulation of GABAergic neurons and indirect modulation of prolactin release, though the exact mechanism remains incompletely understood 1. Cases in adolescents show onset ranging from days to weeks after initiation or dose escalation, with prolactin levels ranging from normal to markedly elevated 2.

Treatment Approach Based on Cause

For Medication-Induced Hyperprolactinemia (Including Lexapro)

The Endocrine Society guideline provides a clear algorithmic approach 6:

  1. First-line: Stop the offending medication if clinically feasible 6

  2. If discontinuation not possible: Switch to a medication with similar action that doesn't cause hyperprolactinemia 6

    • For antipsychotics: Consider aripiprazole or other prolactin-sparing atypicals 7, 8
    • For SSRIs: Switch to alternative antidepressant class in consultation with prescribing physician
  3. If asymptomatic: No treatment necessary 6

  4. If symptomatic with hypogonadism or low bone mass: Consider estrogen or testosterone replacement therapy 6

  5. Cautious dopamine agonist use: Only as last resort in consultation with prescribing physician, with awareness of potential psychiatric exacerbation risk 6

Important caveat: The guideline explicitly recommends AGAINST routine dopamine agonist use for medication-induced hyperprolactinemia due to risk of psychosis exacerbation (particularly with antipsychotics) and places high value on avoiding adverse effects 6.

For Prolactinomas (Pituitary Adenomas)

The treatment is completely different and highly effective 6:

Cabergoline is the first-line dopamine agonist with superior efficacy:

  • Normalizes prolactin in 92-95% of microadenomas 6
  • Normalizes prolactin in 77-81% of macroadenomas 6
  • Achieves tumor shrinkage in 80-92% of cases 6
  • Typical dosing: 0.25-3 mg/week (occasionally up to 11 mg/week) 6

Bromocriptine is an alternative but less effective:

  • Normalizes prolactin in ~80% of cases 6
  • More side effects and lower compliance 6

Critical Diagnostic Distinction

You must differentiate medication-induced from pathologic causes 7, 4, 5:

  1. Temporarily stop the suspected medication (if safe) to see if prolactin normalizes
  2. Obtain MRI of pituitary if hyperprolactinemia not definitively medication-related 7
  3. Check prolactin levels: Macroadenomas typically have much higher levels (mean 1415 ng/mL) versus microadenomas (mean 99 ng/mL) 6

Monitoring for Symptomatic Hyperprolactinemia

Actively inquire about these symptoms 2:

  • Galactorrhea (inappropriate milk secretion)
  • Menstrual disturbances/amenorrhea
  • Erectile dysfunction/impotence
  • Hypogonadal symptoms
  • Low bone density (check BMD if persistent hyperprolactinemia with reproductive dysfunction) 7

Note: Galactorrhea can occur even with normal or mildly elevated prolactin levels with SSRIs 2.

Bottom Line

Lexapro is a potential cause of hyperprolactinemia, not a treatment. If a patient on Lexapro develops elevated prolactin, the appropriate response is to discontinue or switch the SSRI, not add another medication to treat it. True prolactinomas require dopamine agonist therapy with cabergoline as the preferred agent 6.

References

Research

SSRI-Induced Galactorrhea in Adolescents.

Journal of child and adolescent psychopharmacology, 2026

Research

Drugs and prolactin.

Pituitary, 2008

Research

Medication-induced hyperprolactinemia.

Mayo Clinic proceedings, 2005

Guideline

diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2011

Research

Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.